Activation of TGFβ signaling is responsible for the tumor-promoting action of CAFs, and TGFβ inhibition contributes to the reduction in CAF numbers or CAF activation, exerting anti-cancer effects [66]. The gene discussed is TGFB1; the disease is cancer.